Browse drugs

…nations including Temoniera, sulfhydryl reagent variable (SHV), cefotaxime hydrolysing β-lactamase (Munich) (CTX-M) 1 and CTX-M 9 genes we…

…tis (EAE) mouse model (unable to ferment fibres). Mice were fed β-fructans or control fibre diet beginning at symptom onset (day 14). EAE …

…ity in the treated eyes.Conclusion Subretinal gene therapy with AAV8.hPDE6A did not improve visual function over 1 year and posed risks, in…

…stematic review was undertaken to assess whether use of inhaled methoxyflurane in reduction of anterior shoulder dislocation is associated wit…

…s of the jaw is secondary to the use of antiresorptive therapy (zoledronic acid or denosumab) for bone metastases including management of malig…

…tion was achieved by sequential administration of oestrogen and progesterone.Main outcomes and measures Primary outcomes were a healthy live…

…SH) (OR=0.577, 95% CI 0.422 to 0.789; p=0.001), free thyroxine (FT4) level (OR=1.107, 95% CI 1.009 to 1.214; p=0.031), number of em…

…heral facial palsy 1 year earlier (figure 1), despite receiving prednisolone, valacyclovir and physiotherapy at symptom onset. In addition t…

…d into A549 and NCI-H1650 cells. Afterwards, the AKT activator ‘740 Y-P’ was added to treat the cells with or without siRNA transfectio…

…s hyaluronic acid (HA), hydroxypropylmethylcellulose (HPMC) and chondroitin sulfate (CS). This remains a novel area of research, with very few stud…

…programmed cell death protein 1 (PD-1) antibodies nivolumab and pembrolizumab significantly improved the survival of patients with melanoma w…

…lar and/or ductal surgery. Anti-cholinergic medications such as glycopyrronium bromide and transdermal hyoscine hydrobromide are effective but have fr…